Treatment of sarin exposure.
Schier
Joshua G
JG
Hoffman
Robert S
RS
D000931:Antidotes / Q000627:therapeutic use*; D002619:Chemical Warfare Agents / Q000506:poisoning*; D002800:Cholinesterase Inhibitors / Q000506:poisoning*; D002801:Cholinesterase Reactivators / Q000627:therapeutic use*; D006801:Humans; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D011041:Poisoning / Q000188:drug therapy; D011220:Pralidoxime Compounds / Q000627:therapeutic use*; D012524:Sarin / Q000506:poisoning*
D000931:Antidotes; D002619:Chemical Warfare Agents; D002800:Cholinesterase Inhibitors; D002801:Cholinesterase Reactivators; D018696:Neuroprotective Agents; D011220:Pralidoxime Compounds; D012524:Sarin; C028797:pralidoxime